The US Food and Drug Administration has provided its final approval to the Aurobindo Pharma Ltd for manufacturing Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30...
Glenmark has got the establishment inspection report (EIR) from the US health regulator on closure of inspection of its Ankleshwar plant in Gujarat. It has...
Dr Reddy’s Laboratories has got 13 observations from the US health regulator for its formulation manufacturing facility at Duwada, Vishakhapatnam. Dr Redd’s Laboratories has said...
Cadila Healthcare said that it has received three observations from USFDA for its formulation facility at Baddi, Himachal Pradesh. From February 20 to March 1,...
The Establishment Inspection Report (EIR) has been received by the drug firm Panacea Biotec from the US health regulator after successful inspection of its manufacturing...
Alembic Pharmaceuticals has got the Establishment Inspection Report from the USFDA for its formulation facility located at Panelav in Gujarat. Alembic Pharmaceuticals has said in...
Cadila Healthcare has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing plant in Ahmedabad. Cadila Healthcare Ltd has said...
The US Food and Drug Administration (USFDA) has warned Unimark Remedies on violation of good manufacturing practices at its two plants in Gujarat. It added...